2022 Q4 Form 10-K Financial Statement

#000121390023020725 Filed on March 17, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021 Q4
Revenue $0.00 $545.7K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $239.6K $904.2K
YoY Change 63130.07%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $239.6K $904.2K
YoY Change 63130.28%
Operating Profit
YoY Change
Interest Expense $1.069M $1.819M
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $1.838M
YoY Change
Pretax Income $829.6K $933.8K
YoY Change -65400.98%
Income Tax $213.8K $339.9K
% Of Pretax Income 25.78% 36.4%
Net Earnings $615.8K $593.9K
YoY Change -41631.82%
Net Earnings / Revenue 108.84%
Basic Earnings Per Share
Diluted Earnings Per Share $0.04 $0.04
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $545.7K $545.7K
YoY Change
Cash & Equivalents $545.7K
Short-Term Investments
Other Short-Term Assets $215.6K $215.6K
YoY Change
Inventory
Prepaid Expenses $215.6K
Receivables
Other Receivables
Total Short-Term Assets $761.3K $761.3K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $127.8M $127.8M
YoY Change
Other Assets $35.87K $35.87K
YoY Change -80.11%
Total Long-Term Assets $127.8M $127.8M $180.3K
YoY Change 70776.15%
TOTAL ASSETS
Total Short-Term Assets $761.3K $761.3K
Total Long-Term Assets $127.8M $127.8M $180.3K
Total Assets $128.6M $128.6M $180.3K
YoY Change 71198.28% 71198.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $439.1K $439.1K
YoY Change
Accrued Expenses $5.000K $5.000K
YoY Change -83.6%
Deferred Revenue
YoY Change
Short-Term Debt $125.3K $125.3K
YoY Change 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $909.3K $909.3K $156.8K
YoY Change 480.03% 480.04%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $909.3K $909.3K $156.8K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $5.232M $5.232M $156.8K
YoY Change 3237.24% 3237.26%
SHAREHOLDERS EQUITY
Retained Earnings -$3.895M -$1.430K
YoY Change 272284.2%
Common Stock $12.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.895M $123.3M $23.57K
YoY Change
Total Liabilities & Shareholders Equity $128.6M $128.6M $180.3K
YoY Change 71198.28% 71198.68%

Cashflow Statement

Concept 2022 Q4 2022 2021 Q4
OPERATING ACTIVITIES
Net Income $615.8K $593.9K
YoY Change -41631.82%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$28.70K -$725.1K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$126.0M
YoY Change
Cash From Investing Activities $0.00 -$126.0M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $123.5M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $127.2M
YoY Change
NET CHANGE
Cash From Operating Activities -28.70K -$725.1K
Cash From Investing Activities 0.000 -$126.0M
Cash From Financing Activities 0.000 $127.2M
Net Change In Cash -28.70K $545.7K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$28.70K -$725.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
usd
us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41323
CY2022 dei Entity Registrant Name
EntityRegistrantName
NUBIA BRAND INTERNATIONAL CORP.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-1993879
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
13355 Noel Rd,
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1100
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75240
CY2022 dei City Area Code
CityAreaCode
(972)
CY2022 dei Local Phone Number
LocalPhoneNumber
918-5120
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2022 dei Trading Symbol
TradingSymbol
NUBI
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
123006000 usd
CY2022 dei Auditor Firm
AuditorFirmId
688
CY2022 dei Auditor Name
AuditorName
Marcum llp
CY2022 dei Auditor Location
AuditorLocation
Hartford, CT
CY2022Q4 us-gaap Cash
Cash
545655 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
215628 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
761283 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
127782882 usd
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
180341 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35870 usd
CY2022Q4 us-gaap Assets
Assets
128580035 usd
CY2021Q4 us-gaap Assets
Assets
180341 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
439086 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
491 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
339899 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
5000 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
30000 usd
CY2021Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
939 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
125341 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
125341 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
909326 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
156771 usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
4322500 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5231826 usd
CY2021Q4 us-gaap Liabilities
Liabilities
156771 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
127242983 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12 usd
CY2022Q4 nubi Common Stock Value1
CommonStockValue1
308 usd
CY2021Q4 nubi Common Stock Value1
CommonStockValue1
316 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24684 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3895094 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1430 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3894774 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
23570 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128580035 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
180341 usd
CY2022 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
95000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
809193 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1430 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
904193 usd
us-gaap Operating Expenses
OperatingExpenses
1430 usd
CY2022 us-gaap Investment Income Dividend
InvestmentIncomeDividend
1812882 usd
CY2022 us-gaap Interest And Other Income
InterestAndOtherIncome
5683 usd
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
19432 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1837997 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
933804 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1430 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
339899 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
593905 usd
us-gaap Net Income Loss
NetIncomeLoss
-1430 usd
nubi Issuance Of Class B Common Stock To Sponsor
IssuanceOfClassBCommonStockToSponsor
25000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1430 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
23570 usd
CY2022 nubi Proceeds Allocated To Public Warrants
ProceedsAllocatedToPublicWarrants
3755675 usd
CY2022 nubi Proceeds From Private Warrants
ProceedsFromPrivateWarrants
5405000 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-234654 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
776815 usd
CY2022 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-12942102 usd
CY2022 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-1272983 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
593905 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3894774 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
593905 usd
us-gaap Net Income Loss
NetIncomeLoss
-1430 usd
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
939 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
1812882 usd
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-19432 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
215628 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
35870 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
339899 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
424906 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
491 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-725102 usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
125970000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-125970000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
123500000 usd
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
5405000 usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
-1235000 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
429243 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
127240757 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
545655 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
545655 usd
CY2022Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
25000 usd
CY2021Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
30000 usd
CY2022Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
939 usd
CY2022 nubi Deferred Underwriters Compensation Charged To Temporary Equity In Connection With The Public Of
DeferredUnderwritersCompensationChargedToTemporaryEquityInConnectionWithThePublicOf
4322500 usd
CY2022 nubi Class A Common Stock Measurement Adjustment
ClassACommonStockMeasurementAdjustment
12942102 usd
CY2021Q4 nubi Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
25000 usd
CY2022 nubi Fair Value Of Representative Shares
FairValueOfRepresentativeShares
776815 usd
CY2022 nubi Fair Value Of Overallotment Option
FairValueOfOverallotmentOption
19432 usd
CY2022 nubi Class A Common Stock Redeemable Current Period Remeasurement Adjustment
ClassACommonStockRedeemableCurrentPeriodRemeasurementAdjustment
1272983 usd
us-gaap Notes Issued1
NotesIssued1
125341 usd
CY2022Q1 nubi Gross Proceeds
GrossProceeds
405000 usd
CY2022Q4 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Percent Debt Securities
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerSharePercentDebtSecurities
0.80 pure
CY2022Q4 nubi Public Price Per Share
PublicPricePerShare
10.2
CY2022 nubi Aggregate Share Percentage
AggregateSharePercentage
0.15 pure
CY2022 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
1 pure
CY2022Q4 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
1235000 usd
CY2022 us-gaap Payments For Fees
PaymentsForFees
2470000 usd
CY2022 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
100000 usd
CY2022 nubi Reduction In Other Assets Per Shares
ReductionInOtherAssetsPerShares
10.2
CY2022 us-gaap Sale Of Trust Assets To Pay Expenses
SaleOfTrustAssetsToPayExpenses
545655 usd
CY2022 nubi Working Capital Deficit
WorkingCapitalDeficit
148043 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the balance sheet which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p>
CY2022 us-gaap Payments To Invest In Decommissioning Fund
PaymentsToInvestInDecommissioningFund
127800000 usd
us-gaap Payments To Invest In Decommissioning Fund
PaymentsToInvestInDecommissioningFund
0 usd
CY2022Q4 us-gaap Employee Stock Ownership Plan Esop Deferred Shares
EmployeeStockOwnershipPlanESOPDeferredShares
4322500 usd
CY2022 us-gaap Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued
DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
776815 usd
CY2022 us-gaap Taxes Other
TaxesOther
100000 usd
CY2022 us-gaap Sale Leaseback Transaction Gross Proceeds Financing Activities
SaleLeasebackTransactionGrossProceedsFinancingActivities
123500000 usd
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
3755675 usd
CY2022 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
6716427 usd
CY2022Q4 us-gaap Deferred Finance Costs Ownshare Lending Arrangement Issuance Costs Gross
DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsGross
10472102 usd
CY2022 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
12942102 usd
CY2022 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
1272983 usd
CY2022Q4 nubi Common Stock Subject To Possible Redemption
CommonStockSubjectToPossibleRedemption
127242983 usd
CY2022 nubi Percentage Of Exicse Tax
PercentageOfExicseTax
0.01 pure
CY2023Q1 us-gaap Preferred Stock Dividends Shares
PreferredStockDividendsShares
337500 shares
CY2022 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
337500 shares
nubi Subject To Forfeiture
SubjectToForfeiture
412500 shares
CY2022Q1 nubi Aggregate To Founder Shares
AggregateToFounderShares
3162500 shares
CY2022 nubi Percentage Of Issued And Outstanding
PercentageOfIssuedAndOutstanding
0.20 pure
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
CY2022Q1 nubi Purchase Of Underwriters Units
PurchaseOfUnderwritersUnits
1350000 shares
CY2022Q1 nubi Offering Price Per Unit
OfferingPricePerUnit
10
CY2022Q1 nubi Additional Gross Proceeds
AdditionalGrossProceeds
13500000 usd
CY2022 us-gaap Sale Leaseback Transaction Gross Proceeds Investing Activities
SaleLeasebackTransactionGrossProceedsInvestingActivities
5000000 usd
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
11.5
CY2022Q1 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
405000 shares
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1
CY2022Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
405000 usd
CY2022 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
75000 shares
CY2022 us-gaap Business Combination Control Obtained Description
BusinessCombinationControlObtainedDescription
The holders of the Founder Shares have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property. 
CY2021Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
300000 usd
CY2022 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
125341 usd
CY2021 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
125341 usd
CY2022Q2 nubi Share Issued Price Per Share
ShareIssuedPricePerShare
1
CY2022 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
2841 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
0 usd
CY2021 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
939 usd
CY2022 us-gaap Other Expenses
OtherExpenses
10000 usd
CY2022 us-gaap Related Party Tax Expense Due To Affiliates Deferred
RelatedPartyTaxExpenseDueToAffiliatesDeferred
95000 usd
CY2022 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
1500000 usd
CY2022 nubi Warrant Price
WarrantPrice
1
CY2022 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
1650000 shares
CY2022 nubi Aggregate Amount
AggregateAmount
4322500 usd
CY2022Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
1350000 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
10 shares
CY2022Q1 us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
13500000 usd
CY2022Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
19432 usd
CY2022 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
776815 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022 us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.20 pure
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11580000 shares
CY2022 us-gaap Preferred Stock Reason Why Security Is Not Redeemable
PreferredStockReasonWhySecurityIsNotRedeemable
Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $18.00 — Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants:  ●in whole and not in part;   ●at a price of $0.01 per Public Warrant;   ●upon a minimum of 30 days’ prior written notice of redemption, or the 30-day redemption period to each warrant holder; and   ●if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganization, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to warrant holders.  
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
339889 usd
CY2022 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
339889 usd
CY2022Q1 nubi Over Allotment Option Liability
OverAllotmentOptionLiability
19432 usd
CY2022 us-gaap Gain On Fair Value Hedge Ineffectiveness
GainOnFairValueHedgeIneffectiveness
19432 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.00055 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0017 pure
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y1M13D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y29D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.046 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.046 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 nubi Representative Shares
RepresentativeShares
123500 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
6.29
CY2022 nubi Additionals Collateral Aggregate Fair Value
AdditionalsCollateralAggregateFairValue
776815 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
147881 usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
300 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
147881 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
300 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
147881 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
300 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
147481 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
300 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 nubi Change In Fair Value Of Overallotment Liability
ChangeInFairValueOfOverallotmentLiability
-0.0044 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.1584 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.364 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0 pure
CY2022Q4 us-gaap Common Stock Discount On Shares
CommonStockDiscountOnShares
70000000 usd
CY2022Q4 us-gaap Due From Officers Or Stockholders
DueFromOfficersOrStockholders
700000000 usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22500000 shares
CY2022 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
225000000 usd
CY2021Q4 us-gaap Cash
Cash
usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
usd
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
usd
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
usd
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
usd
CY2022Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
usd
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
usd
us-gaap Interest And Other Income
InterestAndOtherIncome
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
usd
CY2022 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
nubi Deferred Underwriters Compensation Charged To Temporary Equity In Connection With The Public Of
DeferredUnderwritersCompensationChargedToTemporaryEquityInConnectionWithThePublicOf
usd
nubi Class A Common Stock Measurement Adjustment
ClassACommonStockMeasurementAdjustment
usd
CY2022Q4 nubi Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
usd
nubi Fair Value Of Representative Shares
FairValueOfRepresentativeShares
usd
nubi Fair Value Of Overallotment Option
FairValueOfOverallotmentOption
usd
nubi Class A Common Stock Redeemable Current Period Remeasurement Adjustment
ClassACommonStockRedeemableCurrentPeriodRemeasurementAdjustment
usd
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
usd
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
usd
CY2022 nubi Deferred Tax Asset Net Of Allowance
DeferredTaxAssetNetOfAllowance
usd
CY2021 nubi Deferred Tax Asset Net Of Allowance
DeferredTaxAssetNetOfAllowance
usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
usd
CY2021 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit Intraperiod Tax Allocation
IncomeTaxExpenseBenefitIntraperiodTaxAllocation
usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
pure
CY2021 nubi Change In Fair Value Of Overallotment Liability
ChangeInFairValueOfOverallotmentLiability
pure
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001881551

Files In Submission

Name View Source Status
0001213900-23-020725-index-headers.html Edgar Link pending
0001213900-23-020725-index.html Edgar Link pending
0001213900-23-020725.txt Edgar Link pending
0001213900-23-020725-xbrl.zip Edgar Link pending
f10k2022ex31-1_nubiabrand.htm Edgar Link pending
f10k2022ex31-2_nubiabrand.htm Edgar Link pending
f10k2022ex32-1_nubiabrand.htm Edgar Link pending
f10k2022ex32-2_nubiabrand.htm Edgar Link pending
f10k2022ex4-5_nubiabrand.htm Edgar Link pending
f10k2022_nubiabrand.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
f10k2022_nubiabrand_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nubi-20221231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nubi-20221231_cal.xml Edgar Link unprocessable
nubi-20221231_def.xml Edgar Link unprocessable
nubi-20221231_lab.xml Edgar Link unprocessable
nubi-20221231_pre.xml Edgar Link unprocessable